TMO vs DXCM
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs DexCom, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | DXCM |
|---|---|---|
| Price | $700.22 | $83.33 |
| Market cap | $259.44B | $31.08B |
| P/E ratio | 36.9 | 32.8 |
| ROE | 13.38% | 37.67% |
| Profit margin | 14.94% | 19.42% |
| Revenue growth | 9.10% | 11.20% |
| Dividend yield | 0.27% | 0.00% |
| Beta | 0.84 | 1.44 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs DXCM in plain English
- TMO is the bigger company — about 8.3× the market cap of DXCM.
- DXCM is cheaper on earnings (P/E 32.8 vs 36.9).
- DXCM earns a higher return on equity (38% vs 13%).
- DXCM is growing revenue faster (11% vs 9%).
- TMO pays a dividend (0.27%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
DXCM return calculator
See what $1,000 in DexCom, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.